MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
July 16, 2021

Researchers Issue Recommendations for Managing Failure of Dupilumab for Atopic Dermatitis

By Andrew John, /alert Contributor
A recently published review discusses how clinicians should handle treatment failure or inadequate response in patients taking dupilumab for atopic dermatitis...
Researchers Issue Recommendations for Managing Failure of Dupilumab for Atopic Dermatitis
July 14, 2021

FDA Approves Secukinumab for Children with Plaque Psoriasis

By Adam Hochron
The FDA has approved secukinumab to treat patients over the age of 6 who have moderate to severe plaque psoriasis and are eligible for systemic therapy or phototherapy...
FDA Approves Secukinumab for Children with Plaque Psoriasis
July 13, 2021

FDA Grants Tezepelumab Priority Review as Asthma Treatment

By Adam Hochron
The FDA has granted Priority Review for tezepelumab and accepted a Biologics License Application (BLA) for patients with asthma...
FDA Grants Tezepelumab Priority Review as Asthma Treatment
July 9, 2021

Pembrolizumab, Chemotherapy Extends PFS, Overall Survival for Metastatic Cervical Cancer

By Adam Hochron

Results of the phase 3 KEYNOTE-826 trial showed the combination of pembrolizumab and chemotherapy met its primary endpoints of overall survival and progression-free survival for the first line treatment patients with ...
Pembrolizumab, Chemotherapy Extends PFS, Overall Survival for Metastatic Cervical Cancer
July 8, 2021

FDA Approves Secukinumab for Children with Plaque Psoriasis

By Adam Hochron
The FDA has approved secukinumab to treat patients over the age of 6 who have moderate to severe plaque psoriasis and are eligible for systemic therapy or phototherapy...
FDA Approves Secukinumab for Children with Plaque Psoriasis
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

Onsite contraceptive services curb unintended pregnancies in women with opioid use disorder

By Marilynn Larkin NEW YORK (Reuters Health) - For women with opioid use disorder (OUD) at risk for unintended pregnancy, onsite contraceptive services are likely more effective than usual care, but Read More »

Success rates for coronary re-access after TAVR higher in patients with short stent-frame prostheses

By Marilynn Larkin NEW YORK (Reuters Health) - Acute coronary syndrome (ACS) patients who have undergone transcatheter aortic valve replacement (TAVR) may still undergo coronary angiography (CA) or Read More »

Vector-based vaccines likely more effective in patients on rituximab

By Marilynn Larkin NEW YORK (Reuters Health) - In patients treated with B cell-depleting rituximab, vector-based vaccines that don't induce a type 1 interferon (IFN-1) response will likely enable a Read More »

Genes have role in common-cold protection against COVID-19

By Reuters Staff (Reuters) - In some people, past exposure to common-cold coronaviruses seems to prepare the immune system to fight the COVID-19 coronavirus, but it has not been clear why this is not Read More »

Separate unvaccinated healthcare staff from unvaccinated patients, researchers advise

By Reuters Staff (Reuters) - With COVID-19 vaccination coverage incomplete among residents and staff at long-term care facilities, researchers have come up with a way to limit transmission in those Read More »

Wearable warning device reduces collisions for the blind and visually impaired

By Linda Carroll (Reuters Health) - A wearable computerized vision device may reduce collisions among blind and visually impaired people who use a long cane and/or guide dog, a new study suggests. In Read More »

Even low lead levels in drinking water tied to worse kidney disease outcomes

By Lisa Rapaport (Reuters Health) - Kidney disease patients may have lower hemoglobin levels and take higher doses of medication to treat anemia when they're exposed to lead in their drinking water, Read More »

EXCLUSIVE-'QAnon Shaman' in plea negotiations after mental health diagnosis -lawyer

By Sarah N. Lynch WASHINGTON (Reuters) - The participant in the Jan. 6 U.S. Capitol riots nicknamed the "QAnon Shaman" is negotiating a possible plea deal with prosecutors, after prison psychologists Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information